SANA Pharmaceutical Research Co.
SANA Pharmaceutical Research Co., commonly referred to as SANA Pharma, is a leading player in the pharmaceutical industry, headquartered in Jordan (JO). Established in 2005, the company has made significant strides in research and development, focusing on innovative solutions in the fields of oncology, cardiology, and neurology. With a commitment to quality and efficacy, SANA Pharma offers a diverse range of products, including generic medications and specialised therapies that cater to unmet medical needs. The company is recognised for its rigorous clinical trials and adherence to international standards, positioning it as a trusted name in the market. SANA Pharma's dedication to advancing healthcare has earned it notable achievements, including partnerships with global research institutions and a growing presence in major operational regions across the Middle East and beyond.
DitchCarbon Score
How does SANA Pharmaceutical Research Co.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Furniture Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
SANA Pharmaceutical Research Co.'s score of 0 is lower than 85% of the industry. This can give you a sense of how well the company is doing compared to its peers.
SANA Pharmaceutical Research Co.'s reported carbon emissions
SANA Pharmaceutical Research Co., headquartered in Jordan (JO), currently does not have available carbon emissions data for the most recent year. As a result, specific figures regarding their emissions in kg CO2e, including Scope 1, 2, or 3 emissions, are not provided. Additionally, there are no documented reduction targets or climate pledges outlined by the company. This absence of information suggests that SANA Pharmaceutical Research Co. may still be in the early stages of developing a comprehensive climate strategy or reporting framework. In the context of the pharmaceutical industry, companies are increasingly recognising the importance of addressing carbon emissions and committing to sustainability initiatives. As such, SANA Pharmaceutical Research Co. may benefit from establishing clear climate commitments and reduction targets to align with industry standards and expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
SANA Pharmaceutical Research Co. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
